Gretchen Kimmick

TL;DR: Screening tools do not replace GA but are recommended in a busy practice in order to identify those patients in need of full GA and guided multidisciplinary interventions.

TL;DR: 1 year of extended adjuvant therapy with neratinib, administered after chemotherapy and trastuzumab, significantly reduced the proportion of clinically relevant breast cancer relapses-ie, those that might lead to death, such as distant and locoregional relapses outside the preserved breast-without increasing the risk of long-term toxicity.

TL;DR: Several underused solutions are offered to expand clinical trials to include older adults with cancer, but these recommendations alone will not solve the evidence gap in geriatric oncology, and efforts are needed to meet older and frail adults where they are by expanding clinical trials designed specifically for this population and leveraging real‐world data.

TL;DR: Prescription fill, adherence, and persistence to adjuvant hormonal therapy among socioeconomically disadvantaged women are low, and improving use of adjuant hormonal therapy may lead to lower breast cancer-specific mortality in this population.

TL;DR: Some newer antidepressants and gabapentin, within 4 weeks of therapy initiation, decrease hot flashes more than placebo.